Why do drugs work in CLL?
Plunkett
W
W
University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Begleiter
A
A
Liliemark
J O
JO
Reed
J C
JC
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use*; D017338:Cladribine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D001084:Vidarabine Phosphate; D002699:Chlorambucil; C042382:fludarabine phosphate; D017338:Cladribine